Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11
G. W. Abrams, S. P. Azen, B. W. McCuen 2nd, H. W. Flynn Jr, M. Y. Lai and S. J. Ryan
Kresge Eye Institute, Wayne State University, Detroit, Mich, USA.
BACKGROUND: The Silicone Study evaluated the outcomes of vitreoretinal
surgery for retinal detachment with proliferative vitreoretinopathy (PVR).
OBJECTIVE: To evaluate short-term (up to 36 months) outcomes in eyes
randomized to silicone oil or perfluoropropane gas and long-term (up to 72
months) outcomes in eyes with attached maculas at 36 months. DESIGN:
Prospective, randomized, multicentered surgical trial. SETTING: Community-
and university-based vitreoretinal practices. PATIENTS: Two-hundred
sixty-five eyes with PVR randomized to perfluoropropane gas and silicone
oil with follow-up through 3 years (cohort 1) and 249 eyes with attached
maculas at 36 months (121 eyes randomized to long-acting gas [either sulfur
hexafluoride or perfluoropropane] and 128 eyes randomized to silicone oil)
with follow-up up to 6 years (cohort 2). Both cohorts consisted of eyes
that had and had not undergone vitrectomy for PVR (groups 1 and 2,
respectively) before randomization. Of the 265 eyes in cohort 1, 24-month
follow-up data were available for 218 eyes (82%) and 36-month follow-up
data were available for 196 eyes (74%). Of 208 eyes in cohort 2, 48-month
follow-up data were available for 146 eyes (70%), 60-month follow-up data
for 119 eyes (57%), and 72-month follow-up data for 73 eyes (35%).
INTERVENTIONS: Vitrectomy surgery for PVR with a long-acting gas or
silicone oil as the intraocular tamponade. MAIN OUTCOME MEASURES: Changes
in visual acuity, recurrent retinal detachment, and incidence of
complications. RESULTS: In group 1 of cohort 1, compared with oil-treated
eyes, gas-treated eyes had a higher rate of complete retinal reattachment
from 18 to 36 months (P < .05). No other differences were found. In
group 2 of cohort 1, no notable differences were found between treatment
arms. In cohort 2, during 6 years of follow-up, attachment of the macula
was maintained for all eyes. No notable differences in the rates of
complete retinal attachment, visual acuity of 5/200 or better, or glaucoma
were found between treatment groups. In contrast, gas-treated eyes had more
hypotony (P < .001). Silicone oil-treated eyes that underwent subsequent
surgery were more likely to have the oil retained (P = .02). Compared with
oil-retained eyes, oil-removed eyes had higher rates of complete posterior
attachment (P = .01) and of a visual acuity of 5/200 or better (P <
.001) and less keratopathy (P < .05). Compared with oil-removed eyes,
gas-treated eyes had a worse visual acuity outcome (P < .05) and more
hypotony (P < .01). CONCLUSION: The Silicone Study showed that silicone
oil and perfluoropropane gas were equal in most respects for the management
of retinal detachments with PVR. Success in the first surgery for PVR is
paramount for obtaining better visual results. Overall, surgery for PVR had
a high likelihood of retinal reattachment, and if anatomically and visually
successful at 3 years, there is an excellent chance that the results will
be maintained over the long-term.
